| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/11/2013 | US8461358 Fluorescent probe for measuring protease |
| 06/11/2013 | US8461323 Characterization of granulocytic ehrlichia and methods of use |
| 06/11/2013 | US8461321 Nucleic acids encoding a deletion variant of uPAR |
| 06/11/2013 | US8461309 Inhibitor protein of the wnt signal pathway |
| 06/11/2013 | US8461306 Therapeutic use of anti-CS1 antibodies |
| 06/11/2013 | US8461304 Antibodies |
| 06/11/2013 | US8460920 Method for the purification of adenovirus particles |
| 06/11/2013 | US8460914 Decreasing potential iatrogenic risks associated with vaccines and vaccine antigens |
| 06/11/2013 | US8460912 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 06/11/2013 | US8460890 Detection and measurement of blood-feeding activity |
| 06/11/2013 | US8460888 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 06/11/2013 | US8460886 Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human PD-1 antibody on cancers |
| 06/11/2013 | US8460709 Pharmaceutical microparticles |
| 06/11/2013 | US8460683 Protein or glycoprotein from Haliotis midae and its use as an immunotherapy agent |
| 06/11/2013 | US8460682 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 06/11/2013 | US8460681 Sequences of Brachyspira, immunogenic compounds, methods for preparation and use thereof |
| 06/11/2013 | US8460680 Polyvalent chimeric rubella virus-based vaccines |
| 06/11/2013 | US8460679 Glycolipid adjuvant compositions |
| 06/11/2013 | US8460678 Use of triplex structure DNA in transferring nucleotide sequences |
| 06/11/2013 | US8460676 Composition comprising VLP and amyloid beta peptide |
| 06/11/2013 | US8460675 Viral chemokine-antigen fusion proteins |
| 06/11/2013 | US8460674 HSV-1 epitopes and methods for using same |
| 06/11/2013 | US8460673 Fusion protein inhibiting osteoclast formation, preparation method and medicine compositions thereof |
| 06/11/2013 | US8460672 Mosaic protein and nucleic acid vaccines against hepatitis C virus |
| 06/11/2013 | US8460671 Compositions and methods for the therapy and diagnosis of influenza |
| 06/11/2013 | US8460670 Fully human influenza M2 specific antibodies |
| 06/11/2013 | US8460669 Compositions and methods for identifying response targets and treating flavivirus infection responses |
| 06/11/2013 | US8460668 Interferon alpha receptor I antibodies and their use |
| 06/11/2013 | US8460667 EPHA2 receptor antagonist antibodies |
| 06/11/2013 | US8460666 Human binding molecules having killing activity against staphylococci and uses thereof |
| 06/11/2013 | US8460665 Compositions and methods including a recombinant human MAB that promotes CNS remyelination |
| 06/11/2013 | US8460664 Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes |
| 06/11/2013 | US8460663 Stabilized liquid anti-RSV antibody formulations |
| 06/11/2013 | US8460662 Compositions and methods relating to anti-IGF-1 receptor antibodies |
| 06/11/2013 | US8460661 Methods of using antibodies that bind the glutamate ligand binding region of Notch1 |
| 06/11/2013 | US8460660 Anti-mesothelin antibodies |
| 06/11/2013 | US8460659 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases |
| 06/11/2013 | US8460658 Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 06/11/2013 | US8460657 Modulation of the TrpV: Vps10p receptor system for the treatment of pain |
| 06/11/2013 | US8460648 Probiotic recolonisation therapy |
| 06/11/2013 | US8460642 Boldline compounds for promoting bone growth |
| 06/11/2013 | US8459046 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product |
| 06/11/2013 | CA2604432C Novel vaccine formulations |
| 06/11/2013 | CA2583689C Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 06/11/2013 | CA2567795C Methods of treating type i diabetes by blocking vegf-mediated activity |
| 06/11/2013 | CA2533512C Antagonists and agonists of ldcam and methods of use |
| 06/11/2013 | CA2520936C An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
| 06/11/2013 | CA2513388C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2468733C Antibodies against monocyte chemotactic proteins |
| 06/11/2013 | CA2442839C Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 06/11/2013 | CA2437453C Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/11/2013 | CA2388461C Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
| 06/11/2013 | CA2377381C Neovascular-targeted immunoconjugates |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/06/2013 | WO2013082558A1 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| 06/06/2013 | WO2013082500A2 Vaccine for falciparum malaria |
| 06/06/2013 | WO2013082394A1 Immunogenic plasmodium falciparum antigen compositions and uses thereof |
| 06/06/2013 | WO2013082366A1 Anti-ceacam1 recombinant antibodies for cancer therapy |
| 06/06/2013 | WO2013082327A1 Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof |
| 06/06/2013 | WO2013082317A2 Recombinant gallid herpesvirus 3 (mdv serotype 2) vectors expressing antigens of avian pathogens and uses thereof |
| 06/06/2013 | WO2013082298A2 Immunological composition for clostridium difficile |
| 06/06/2013 | WO2013082292A1 A method to enhance cognition |
| 06/06/2013 | WO2013082254A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| 06/06/2013 | WO2013081928A2 Method and composition for hyperthermally treating cells |
| 06/06/2013 | WO2013081706A1 Methods and compositions for increasing arylsulfatase a activity in the cns |
| 06/06/2013 | WO2013081571A2 Isolated lyssavirus nucleic acid and protein sequences |
| 06/06/2013 | WO2013081379A1 Drug conjugate comprising drug linked to human c-met antibody, and use therefor |
| 06/06/2013 | WO2013081371A1 Binding molecule generated from human b-cells and capable of neutralizing influenza a viruses |
| 06/06/2013 | WO2013081233A1 Cell killing fusion peptide exhibiting tumor cell-specific necrosis induction and tumor regression |
| 06/06/2013 | WO2013081143A1 Drug containing carrier into cell for forming immune complex |
| 06/06/2013 | WO2013080187A1 Hpv chimaeric particle |
| 06/06/2013 | WO2013079970A1 Polypeptide adjuvant |
| 06/06/2013 | WO2013079713A1 Improving trabeculectomy outcome |
| 06/06/2013 | WO2013079473A1 Influenza virus vaccines and uses thereof |
| 06/06/2013 | WO2013079207A1 Novel targets of acinetobacter baumannii |
| 06/06/2013 | WO2013079174A1 Anti-pd-l1 antibodies and uses thereof |
| 06/06/2013 | WO2013078511A1 Anti-npy and pyy antibodies and uses thereof |
| 06/06/2013 | WO2013059548A9 Compositions and methods for treating cancer using jak2 inhibitor |
| 06/06/2013 | WO2013052095A3 Vaccine |
| 06/06/2013 | WO2013051878A3 Antibody specifically binding to epitope in sema domain of c-met |
| 06/06/2013 | WO2013045668A3 Immunotherapy composition and regimen for treating hepatitis c virus infection |
| 06/06/2013 | WO2013032942A9 Influenza viruses with mutant pb2 gene segment as live attenuated vaccines |
| 06/06/2013 | WO2013019623A3 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject |
| 06/06/2013 | WO2013006514A3 Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases |
| 06/06/2013 | WO2012139106A3 Herpes simplex virus |
| 06/06/2013 | WO2012106473A8 Dosing for treatment with anti-egfl7 antibodies |
| 06/06/2013 | US20130143294 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 06/06/2013 | US20130142865 Fixed dosing of her antibodies |
| 06/06/2013 | US20130142864 In vivo targeting of dendritic cells |
| 06/06/2013 | US20130142833 Circulation of components during homogenization of emulsions |
| 06/06/2013 | US20130142827 Induction of immune response |
| 06/06/2013 | US20130142825 Method of preventing and treating inflammatory diseases and disorders with abscisic acid |
| 06/06/2013 | US20130142824 Novel modified live-attenuated vaccines (mlv) created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv) |
| 06/06/2013 | US20130142823 Cmv glycoproteins and recombinant vectors |
| 06/06/2013 | US20130142821 Hapten-Carrier Conjugates and Uses Thereof |
| 06/06/2013 | US20130142817 Microbial delivery system |
| 06/06/2013 | US20130142815 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase |
| 06/06/2013 | US20130142812 Antibody and use thereof |